What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Blue Collar Picks
Big buy
$50M open-market purchase by Simeon George, Director at Crispr Therapeutics AG, filed July 17, 2025. Learn more
What this is
This page shows the rows from one Form 4 filing as reported to the SEC.
Why it matters
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Simeon George · Director at Crispr Therapeutics AG
Simeon George bought $50M of CRSP (Crispr Therapeutics AG).
Insider purchase
Simeon George, a Director, reported a $50M open-market purchase equal to 1.0% of CRSP's market cap.
Simeon George (Director) bought 960,983 shares of CRSP, Crispr Therapeutics AG, Healthcare ($4.90B market cap), at $52.03 per share on July 16, 2025 for a total of $50M (1.0% of the market cap).
Simeon George
Director
Permalink https://bluecollarpicks.com/insider-trading/CRSP/buy/51111
Market context
Last enriched June 20, 2026 at 8:57 AM EDT.
Filings
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
| This filing | Big Buy Director | $50M | |
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Sell Officer | $152K | ||
Exercise and Hold Officer | Not reported | ||
Gift CFO | Not reported | ||
Sell CFO | $194.1K | ||
Sell CFO | $282.2K | ||
Exercise and Hold CFO | Not reported | ||
Exercise and Hold CFO | Not reported | ||
Sell Officer | $166.5K | ||
Exercise and Hold Officer | Not reported | ||
Sell CEO | $499.4K | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CFO | Not reported | ||
Exercise and Hold CFO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Sell Officer | $147.8K | ||
Exercise and Hold Officer | Not reported | ||
Sell CEO | $517.3K | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Sell CEO | $366.3K | ||
Exercise and Hold CEO | Not reported | ||
Sell Officer | $111K | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold CEO | Not reported | ||
Buy Officer | $49.7K | ||
| $1.6M | |||
| $2.1M | |||
| Not reported | |||
| $3.6M | |||
| $446.3K | |||
| $1.1M | |||
| $1.1M | |||
| $300.2K | |||
| Not reported | |||
| $347K | |||
| $280.9K | |||
| $1.1M | |||
| Not reported | |||
Sell CFO | $308.3K | ||
Sell CFO | $194.4K | ||
Sell CFO | $56.9K | ||
Sell CEO | $3.5M | ||
Sell Officer | $71.7K | ||
Selected filing
Select a row to inspect the filing.
Cluster detail
Ticker context
Recent insider activity for this company.
Insider detail
Recent transactions grouped by reporting owner.
Filters
Weekly recap
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.